Year | Asymptomatic infections | Febrile infections | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Allelic type | COI (range) | He | n | Allelic type | COI (range) | He | |||||
FC27 n (%) | IC/3D7 n (%) | FC27 + IC/3D7 n (%) | FC27 n (%) | IC/3D7 n (%) | FC27 + IC/3D7 n (%) | |||||||
2007 | 44 | 4 (4.0) | 22 (17.2) | 18 (9.9) | 2.4 (1–7) | 0.986 | NA | NA | NA | NA | NA | NA |
2008 | 65 | 20 (19.8) | 33 (25.8) | 12 (6.6) | 1.7 (1–5) | 0.969 | 1 | 1 (2.0) | NA | NA | 1 | NA |
2009 | 45 | 12 (11.9) | 11 (8.6) | 22 (12.2) | 2.7 (1–6) | 0.959 | 19 | 13 (26.5) | 3 (23.1) | 3 (10.0) | 2.1 (1–6) | 0.968 |
2010 | 50 | 18 (17.8) | 13 (10.2) | 19 (10.5) | 2.0 (1–7) | 0.967 | 25 | 14 (28.6) | 3 (23.1) | 8 (26.7) | 2.0 (1–6) | 0.965 |
2011 | 48 | 13 (12.9) | 16 (12.5) | 19 (10.5) | 2.5 (1–5) | 0.975 | 18 | 12 (24.5) | 2 (15.4) | 4 (13.3) | 1.6 (1–5) | 0.953 |
2012 | 42 | 17 (16.8) | 5 (3.9) | 20 (11.0) | 2.7 (1–8) | 0.964 | 1 | 1 (2.0) | NA | NA | 1 | NA |
2013 | 36 | 9 (8.9) | 3 (2.3) | 24 (13.3) | 2.6 (1–5) | 0.962 | 7 | 4 (4.2) | NA | 3 (10.0) | 2.4 (1–4) | 0.963 |
2014 | NA | NA | NA | NA | NA | NA | 7 | 2 (4.1) | 1 (7.7) | 4 (13.3) | 2.4 (1–4) | 0.971 |
2015 | 43 | 3 (3.0) | 13 (10.2) | 27 (14.9) | 2.2 (1–5) | 0.959 | 5 | 1 (2.0) | 1 (7.7) | 3 (10.0) | 2.2 (1–4) | NA |
2016 | 21 | 2 (2.0) | 6 (4.7) | 13 (7.2) | 3.0 (1–10) | 0.975 | 4 | 1 (2.0) | 2 (15.4) | 1 (3.3) | 1.5 (1–2) | NA |
2017 | 10 | 1 (1.0) | 5 (3.9) | 4 (2.2) | 2.7 (1–5) | 0.966 | 3 | NA | 1 (7.7) | 2 (6.7) | 1.7 (1–2) | NA |
2018 | 6 | 2 (2.0) | 1 (0.8) | 3 (1.7) | 2.3 (1–5) | 0.934 | 2 | NA | NA | 2 (6.7) | 2.5 (2–3) | NA |
Total (%) | 410 | 101 (24.6) | 128 (31.2) | 181 (44.2) | 2.3 (1–10) | 0.975 | 92 | 49 (53.3) | 13 (14.1) | 30 (32.6) | 2.0 (1–6) | 0.964 |